Strengthening Our Preclinical Services Through T3 Labs Acquisition

Building on our commitment to innovation and excellence, we have expanded our preclinical service capabilities through the acquisition of T3 Labs. This partnership enhances our portfolio by incorporating advanced research technologies and specialized expertise, enabling us to offer comprehensive solutions to our clients. With T3 Labs joining our team, we are better positioned to accelerate development timelines, improve research quality, and support the evolving needs of the medical and pharmaceutical industries.